Karlin Raja Karlmark

2.2k citations
13 papers · 1.8k indexed · 2 hit papers · h-index 10

Karlin Raja Karlmark

13 papers receiving 1.8k citations

Hit Papers

Pharmacological inhibition of the chemokine CCL2 (MCP-1) ...4952009202620142020200400600

Peers

Karlin Raja Karlmark
Comparison fields: 5 of 97
  • Hepatology 783
  • Immunology 572
  • Epidemiology 896
  • Pharmacology 105
  • Cell Biology 119
Replace Costica Aloman with:
Costica Aloman United States
Marie‐Luise Berres Germany
Christer Baeck Germany
Tobias Puengel Germany
Rie Sugimoto Japan
Wing‐Kin Syn United States
Oliver Krenkel Germany
Yutaka Yata Japan
So Yeon Kim South Korea
Kiyohiro Higuchi Japan
Karlin Raja Karlmark relative to Costica Aloman United States Costica Aloman's profile →
Citations per field
00.5×1.5×
Costica Aloman · 1×
Citations per year

Countries citing papers authored by Karlin Raja Karlmark

Since Specialization
Citations

This map shows the geographic impact of Karlin Raja Karlmark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karlin Raja Karlmark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karlin Raja Karlmark more than expected).

Fields of papers citing papers by Karlin Raja Karlmark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karlin Raja Karlmark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karlin Raja Karlmark. The network helps show where Karlin Raja Karlmark may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karlin Raja Karlmark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karlin Raja Karlmark Line = papers co-authored together Karlin Raja Karlmark links everyone, so they are left out of the graph.

All Works

13 of 13 papers shown
#Work
1 20217
2 20219
3 20187
4 2013114
5 201269
6 201189
7
Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injurybreakdown →
2011495
8 2010203
9
Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis #breakdown →
2009627
10 2008114
11 20062
12 200513
13 200545

About Karlin Raja Karlmark

Karlin Raja Karlmark is a scholar working on Hepatology, Pharmacology and Immunology, having authored 13 papers that have together received 1.8k indexed citations. Recurring topics across this work include Liver physiology and pathology (4 papers), Liver Disease and Transplantation (3 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Prenatal Screening and Diagnostics (3 papers), Reproductive System and Pregnancy (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Liver Diseases and Immunity (2 papers) and Cell death mechanisms and regulation (1 paper). The work is most often cited by research in Hepatology (783 citations), Immunology (572 citations) and Epidemiology (896 citations). Karlin Raja Karlmark has collaborated with scholars based in Germany, Austria and France. Frequent co-authors include Frank Tacke, Christian Trautwein, Nikolaus Gaßler, Tom Luedde, Henning W. Zimmermann, Ralf Weiskirchen, Miriam Mérad, Christian Weber, Florent Ginhoux and Hermann E. Wasmuth. Their work appears in journals such as Frontiers in Immunology, Hepatology, Neurochemical Research, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026